Moxetumomab Pasudotox-tdfk and Physostigmine Salicylate
Determining the interaction of Moxetumomab Pasudotox-tdfk and Physostigmine Salicylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: physostigmine
Brand name: Antilirium
Synonyms: Physostigmine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Phytonadione
- Moxetumomab Pasudotox-tdfk-Phytonadione Injection
- Moxetumomab Pasudotox-tdfk-Phytonadione oral/injection
- Moxetumomab Pasudotox-tdfk-Phytonadione Orally Disintegrating Tablets
- Moxetumomab Pasudotox-tdfk-Phytonadione Tablets
- Moxetumomab Pasudotox-tdfk-Pifeltro
- Physostigmine Salicylate-Moxetumomab pasudotox-tdfk Intravenous
- Physostigmine Salicylate-Moxifloxacin
- Physostigmine Salicylate-Moxifloxacin (Systemic)
- Physostigmine Salicylate-Moxifloxacin Hydrochloride
- Physostigmine Salicylate-Moxifloxacin Injection
- Physostigmine Salicylate-Moxifloxacin Intravenous